Zhudihan

Dr. Zhu is a dedicated researcher at the School of Life Science and Technology at China Pharmaceutical University. With a deep focus on the innate immune system and immune dysfunction in ischemic diseases, Dr. Zhu earned a Ph.D. in biology from Nanjing University and specializes in the development of immune therapy for ischemic and autoimmune conditions.

1. Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17+ regulatory T cell, Stem Cell Research & Therapy, 2022

2. Exosomes from adipose-derived stem cells alleviate myocardial infarction via microRNA-31/FIH1/HIF-1α pathway, Journal of Molecular and Cellular Cardiology, 2021

3. Macrophage M2 polarization induced by exosomes from adipose-derived stem cells contributes to the exosomal proangiogenic effect on mouse ischemic hindlimb, Stem Cell Research & Therapy, 2020

4. Human cytomegalovirus reprogrammes haematopoietic progenitor cells into immunosuppressive monocytes to achieve latency, Nature microbiology, 2018